Part 3 - The Pharmaceutical Research Process

This is the third in a series of podcasts specifically dedicated to how good clinical research on pharmaceutical products is planned, conducted, analyzed and approved. Given the recent Plandemic (not a typo), and Covid-19 "vaccine" rollout including mandates for people to either get vaxed or lose their jobs, livelihoods, and in some cases, their families and businesses, I wanted to create a series that would educate people on the process of clinical research - how a new drug gets to market, so that they could make more informed decisions about what they will and will not choose to put in their bodies. The Pharmaceutical Research Process is a complex one, made up of IV Phases to determine safety and efficacy of a new drug. In Episode #3 we will be discussing what happens when an NCE (New Chemical Entity) is identified, after the animal testing, and after the Protocol and Informed Consent is reviewed and approved by an ethics committee for human participants, and how a clinical trial is implemented at participating sites.https://www.linkedin.com/in/b-michele-commins-2a07715/https://vedicalchemy.org/pharma-to-dharmahttps://vedicalchemy.org/resourceshttps://vedicalchemy.org/products-%26-faqshttps://vedicalchemy.org